TSE:MFC

Manulife Financial (MFC.TO)

61.29
+1.37 (2.29%)
as of Sep 3, 2026, 3:52:15 pm Market Open.
1632 watching
0
Investor Insights
star iconSep 3, 2026, 12:00 am

This summary was created by AI, based on 27 opinions in the last 12 months.

Manulife Financial is navigating a complex landscape marked by both growth opportunities and challenges. While the company has reported a strong quarter and shows healthy growth, particularly in Asia and wealth management, concerns exist surrounding the newly imposed tax by the Chinese government on its products. The stock's valuation is drawing mixed reactions, with some experts noting it's currently overbought and trading above 2x book value. However, many analysts maintain a positive outlook, emphasizing its steady dividend yield and potential for long-term growth, particularly if macroeconomic conditions shift in its favor. Despite some recent underperformance compared to peers, strong fundamentals and a reliable business model position Manulife well for the future.

consensus icon
Consensus
Positive
valuation icon
Valuation
Fair Value
review icon
Similar
SLF
WAIT
Likes the company, but recommends buying later in the spring, closer to the closing of the John Hancock deal.
PAST TOP PICK
(A past top pick Oct 7/03. Up 10%.) Expects their part in the mutual fund scandal will be dealt with very quickly.
WAIT
All the life co's. have moved up in terms of price/earnings ratio. Slightly expensive in the short term. Wait for the John Hancock situation to get cleared up before buying.
BUY
They have a clear growth opportunity outside of Canada.
TOP PICK
Likes their acquisition of John Hancock. It improves their footprint and product line in the US. Strong management team. Buy on any weakness.
BUY
Well-run. The John Hancock acquisition makes a lot of sense.
BUY
Has a long term future. Insurance companies will grow in a 10/15% range, dividends included.
TOP PICK
The John Hancock merger is very good for shareholders. Gives Manulife a footprint into the US. Strong management team. Could be some volatility which will be a buying opportunity.
BUY
Acquisition of John Hancock was a good move. A risk will be if John Hancock shareholders decide to sell their shares, but Manulife has a pretty strong buyback position on this. An interesting stock. Well-positioned for the long term.
DON'T BUY
From a fair market value point of view, it has nothing for you. Not terribly bullish in the short term. What they are doing makes good sense and the growth outlook is reasonable.
TOP PICK
(A top pick Oct 6/03. Up 3½%.) Good synergies with the takeover of John Hancock. Cheap at 11 X earnings.
BUY
Likes life insurance companies and this stock had taken a drop to a good price.
WAIT
The deal with John Hancock doesn't close until next April so would wait closer to that date before buying. Some of the US funds may decide to drop John Hancock shares.
TOP PICK
Has dropped with the takeover of John Hancock. As a value investment, three to five years from now it has the prospects to build back up.
TOP PICK
Likes their acquisition of John Hancock. Have done a good job of integrating in the past.
Showing 2,056 to 2,070 of 2,284 entries